Pentraxin levels in non-eosinophilic versus eosinophilic asthma
Pentraxin levels in non-eosinophilic versus eosinophilic asthma
复制标题
非嗜酸性粒细胞性哮喘与嗜酸性粒细胞性哮喘中的五聚蛋白水平
DOI:
10.1111/cea.13168
复制
发表时间:
2018-08-01
影响因子:
6.1
通讯作者:
Xie, Jungang
中科院分区:
文献类型:
--
作者:
Gao, Pengfei;Tang, Kun;Xie, Jungang
BackgroundInnate immunity has been thought to be involved in asthma pathogenesis. Pentraxins, acting as soluble pattern recognition molecules, play an important role in humoral innate immunity. Asthma is a heterogeneous inflammatory disease of airways and can be classified as eosinophilic or non-eosinophilic asthma.ObjectiveTo investigate whether pentraxin levels differ in subjects with eosinophilic versus non-eosinophilic asthma. Furthermore, to access the predictive performance of pentraxin levels for discriminating asthma inflammatory phenotypes.MethodsA total of 80 asthmatic patients and 24 healthy control subjects underwent sputum induction at study inclusion. Differential leucocyte counts were performed on selected sputum. Plasma C-reactive protein (CRP), serum amyloid P (SAP), pentraxin 3 (PTX3), and sputum SAP, PTX3, IL-8 levels were determined by enzyme-linked immunosorbent assay.ResultsSubjects with non-eosinophilic asthma had significantly increased pentraxin levels compared with those with eosinophilic asthma and healthy controls, with median (interquartile range) plasma CRP levels of 0.86 (0.28-2.07), 0.26 (0.14-0.85), and 0.15 (0.09-0.45)mg/L (P